BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28549709)

  • 1. CT-Guided Bone Biopsies in Metastatic Castration-Resistant Prostate Cancer: Factors Predictive of Maximum Tumor Yield.
    Holmes MG; Foss E; Joseph G; Foye A; Beckett B; Motamedi D; Youngren J; Thomas GV; Huang J; Aggarwal R; Alumkal JJ; Beer TM; Small EJ; Link TM
    J Vasc Interv Radiol; 2017 Aug; 28(8):1073-1081.e1. PubMed ID: 28549709
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    van Steenbergen TRF; Smits M; Scheenen TWJ; van Oort IM; Nagarajah J; Rovers MM; Mehra N; Fütterer JJ
    Cardiovasc Intervent Radiol; 2020 Jan; 43(1):147-154. PubMed ID: 31444628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising CT-guided biopsies of sclerotic bone lesions in cancer patients.
    Donners R; Fotiadis N; Figueiredo I; Blackledge M; Westaby D; Guo C; Fenor de la Maza MLD; Koh DM; Tunariu N
    Eur Radiol; 2022 Oct; 32(10):6820-6829. PubMed ID: 35881184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database.
    Hanyok BT; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Posadas EM; Freedland SJ
    Cancer; 2016 Jan; 122(2):222-9. PubMed ID: 26484853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric bone MRI targeting aides lesion selection for CT-guided sclerotic bone biopsies in metastatic castrate resistant prostate cancer.
    Donners R; Figueiredo I; Westaby D; Koh DM; Tunariu N; Carreira S; de Bono JS; Fotiadis N
    Cancer Imaging; 2023 Dec; 23(1):121. PubMed ID: 38102655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer.
    McKay RR; Zukotynski KA; Werner L; Voznesensky O; Wu JS; Smith SE; Jiang Z; Melnick K; Yuan X; Kantoff PW; Montgomery B; Balk SP; Taplin ME
    Prostate Cancer Prostatic Dis; 2014 Dec; 17(4):325-31. PubMed ID: 25091040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow biopsy: RNA isolation with expression profiling in men with metastatic castration-resistant prostate cancer--factors affecting diagnostic success.
    Spritzer CE; Afonso PD; Vinson EN; Turnbull JD; Morris KK; Foye A; Madden JF; Roy Choudhury K; Febbo PG; George DJ
    Radiology; 2013 Dec; 269(3):816-23. PubMed ID: 23925271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image-Guided Percutaneous Omental and Mesenteric Biopsy: Assessment of Technical Success Rate and Diagnostic Yield.
    Vadvala HV; Furtado VF; Kambadakone A; Frenk NE; Mueller PR; Arellano RS
    J Vasc Interv Radiol; 2017 Nov; 28(11):1569-1576. PubMed ID: 28916344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Castration-resistant prostate cancer bone metastasis response measured by 18F-fluoride PET after treatment with dasatinib and correlation with progression-free survival: results from American College of Radiology Imaging Network 6687.
    Yu EY; Duan F; Muzi M; Deng X; Chin BB; Alumkal JJ; Taplin ME; Taub JM; Herman B; Higano CS; Doot RK; Hartfeil D; Febbo PG; Mankoff DA
    J Nucl Med; 2015 Mar; 56(3):354-60. PubMed ID: 25635138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/CT-guided percutaneous biopsy of FDG-avid metastatic bone lesions in patients with advanced lung cancer: a safe and effective technique.
    Guo W; Hao B; Chen HJ; Zhao L; Luo ZM; Wu H; Sun L
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):25-32. PubMed ID: 27444682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and Safety of Percutaneous CT-Guided Rib Biopsy.
    Baffour FI; Moynagh MR; Eiken PW; Welch BT; Kurup AN; Atwell TD; Schmit GD
    J Vasc Interv Radiol; 2019 Jan; 30(1):82-86. PubMed ID: 30527651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous CT-guided biopsy of lytic bone lesions in patients clinically suspected of lung cancer: Diagnostic performances for pathological diagnosis and molecular testing.
    Toffart AC; Asfari S; Mc Leer A; Reymond E; Jankowski A; Moro-Sibilot D; Stephanov O; Ghelfi J; Lantuejoul S; Ferretti GR
    Lung Cancer; 2020 Feb; 140():93-98. PubMed ID: 31901769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior PSMA PET-CT Imaging and Hounsfield Unit Impact on Tumor Yield and Success of Molecular Analyses from Bone Biopsies in Metastatic Prostate Cancer.
    Smits M; Ekici K; Pamidimarri Naga S; van Oort IM; Sedelaar MJP; Schalken JA; Nagarajah J; Scheenen TWJ; Gerritsen WR; Fütterer JJ; Mehra N
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33327413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/CT-guided versus CT-guided percutaneous core biopsies in the diagnosis of bone tumors and tumor-like lesions: which is the better choice?
    Wu MH; Xiao LF; Liu HW; Yang ZQ; Liang XX; Chen Y; Lei J; Deng ZM
    Cancer Imaging; 2019 Oct; 19(1):69. PubMed ID: 31665093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous Image-Guided Spinal Lesion Biopsies: Factors Affecting Higher Diagnostic Yield.
    Yang SY; Oh E; Kwon JW; Kim HS
    AJR Am J Roentgenol; 2018 Nov; 211(5):1068-1074. PubMed ID: 30160992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of successful on-purpose tumor biopsies in metastatic cancer patients included in the SHIVA prospective clinical trial.
    Desportes E; Wagner M; Kamal M; Salomon AV; Deniziaut G; Pierron G; Rouleau E; Jouffroy T; Le Tourneau C; Paoletti X; Servois V
    Oncotarget; 2017 Jan; 8(1):1760-1773. PubMed ID: 27655703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients.
    Cho WJ; Oliveira DS; Najy AJ; Mainetti LE; Aoun HD; Cher ML; Heath E; Kim HR; Bonfil RD
    J Transl Med; 2016 Mar; 14():72. PubMed ID: 26975354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous CT-guided sternal biopsy: factors affecting the diagnostic yield.
    Song Y; Kwon JW
    Acta Radiol; 2017 Jul; 58(7):825-833. PubMed ID: 27852642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial experience with dual-energy computed tomography-guided bone biopsies of bone lesions that are occult on monoenergetic CT.
    Burke MC; Garg A; Youngner JM; Deshmukh SD; Omar IM
    Skeletal Radiol; 2019 Apr; 48(4):605-613. PubMed ID: 30343440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time fluoroscopic needle guidance in the interventional radiology suite using navigational software for percutaneous bone biopsies in children.
    Shellikeri S; Setser RM; Hwang TJ; Srinivasan A; Krishnamurthy G; Vatsky S; Girard E; Zhu X; Keller MS; Cahill AM
    Pediatr Radiol; 2017 Jul; 47(8):963-973. PubMed ID: 28474255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.